Thrombopoietin Receptor Agonists Market - Top Companies and Manufacturers

Companies Dominating the Thrombopoietin Receptor Agonist Landscape

Amgen Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Novartis AG
Rigel Pharmaceuticals
Dova Pharmaceuticals
CSL Ltd.
Takeda Pharmaceutical Company Ltd.
AstraZeneca
Bio Products Laboratory
Grifols SA
Octapharma AG

Browse Key Market Insights with Data Illustration:

Thrombopoietin Receptor Agonist Market Size & Share, Forecast Report 2036

In the News

April 30, 2020: Dova Pharmaceuticals, a Swedish company, announced the launch of DOPTELET, a thrombopoietin receptor agonist used for the treatment of immune thrombocytopenia. The product has been granted approval by the China National Medical Products Administration (NMPA) for adult patients with chronic liver disease. The drug was approved based on a double-blind, placebo controlled trial conducted on patients with severe thrombocytopenia and chronic liver disease wherein patients receiving DOPTELET were found to be significantly better than the placebo trial results.

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of thrombopoietin receptor agonist is estimated at USD 1.83 billion.

Thrombopoietin Receptor Agonist Market size was valued at USD 1.74 billion in 2023 and is likely to cross USD 3.95 billion by 2036, expanding at more than 6.5% CAGR during the forecast period i.e., between 2024-2036.

North America industry is poised to account for largest revenue share by 2036, attributed to rising awareness of the rare blood disorders, advanced healthcare facilities, easier access to the treatment of ITP and higher investment in research and development activities.

The major players in the market are Amgen Inc., Novartis AG, Rigel Pharmaceuticals, Dova Pharmaceuticals, CSL Ltd., Takeda Pharmaceutical Company Ltd., AstraZeneca, Bio Products Laboratory, Grifols SA, Octapharma AG, and others.

Thrombopoietin Receptor Agonists Market - Top Companies and Manufacturers

Companies Dominating the Thrombopoietin Receptor Agonist Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What is the size of the thrombopoietin receptor agonist market?

Why is the thrombopoietin receptor agonist sector gaining traction in near future?

Which region accounted for the largest thrombopoietin receptor agonist industry share?

Who are the major thrombopoietin receptor agonist players?